Organ Care System (OCS™) Liver

FDA Premarket Approval P200031

Pre-market Approval Supplement Details

Approval for organ care system (ocs) liver for the indication of: the transmedics® organ care system (ocs) liver is a portable extracorporeal liver perfusion and monitoring system indicated for preservation and monitoring of hemodynamics and metabolic function which allows for ex-vivo assessment of liver allografts from donors after brain death (dbd) or liver allografts from donors after circulatory death (dcd)

DeviceOrgan Care System (OCS™) Liver
Generic NameNormothermic Machine Perfusion System For The Preservation Of Donor Livers Prior To Transplantation
ApplicantTransMedics, Inc.
Date Received2020-06-30
Decision Date2021-09-28
PMAP200031
SupplementS
Product CodeQQK 
Advisory CommitteeGastroenterology/Urology
Expedited ReviewNo
Combination Product No
Applicant Address TransMedics, Inc. 200 Minuteman Road suite 302 andover, MA 01810

Supplemental Filings

Supplement NumberDateSupplement Type
P200031Original Filing
S001 2022-04-08 Normal 180 Day Track No User Fee

NIH GUDID Devices

Device IDPMASupp
B00949381 P200031 000
B00944895 P200031 000
B00944905 P200031 000
B00944915 P200031 000
B00946643 P200031 000
B00946653 P200031 000
B00948895 P200031 000
B00950443 P200031 000
B00950491 P200031 000
B00944707 P200031 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.